Security key
881624209
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA)
CUSIP: 881624209
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Ordinary Shares, par value NIS 0.01 per share
- Total 13F shares
- 665,647,648
- Total 13F value
- $14,670,317,479
- Share change
- +36,069,080
- Put/Call ratio
- 58%
- SEC-reported price per share
- $22.04
- Number of holders
- 576
- Value change
- +$818,691,314
- Number of buys
- 255
- Number of sells
- 234
- Shares outstanding
- 1,148,777,709
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
576
Top holders
10
TEVA full security history
Ownership snapshot
Full 13F holder table
TEVA PHARMACEUTICAL INDUSTRIES LTD SEC filings
TEVA PHARMACEUTICAL INDUSTRIES LTD company facts
Broader feeds
Ownership snapshot
Top reported holders of TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
30 Sep 2024
13F
Lead comparable stake: 5.5%
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 5.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
5.5%
BlackRock, Inc.
3.8%
Ion Asset Management Ltd.
3.2%
Clal Insurance Enterprises Holdin...
3%
MENORA MIVTACHIM HOLDINGS LTD.
2.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
5.5%
|
$1,130,588,540
62,740,763 shares
|
— | 30 Sep 2024 |
| BlackRock, Inc. |
13F
Company
|
3.8%
|
$789,278,929
43,800,163 shares
|
— | 30 Sep 2024 |
| Ion Asset Management Ltd. |
13F
Company
|
3.2%
|
$653,048,801
36,240,222 shares
|
— | 30 Sep 2024 |
| Clal Insurance Enterprises Holdings Ltd |
13F
Company
|
3%
|
$621,337,000
34,543,812 shares
|
— | 30 Sep 2024 |
| MENORA MIVTACHIM HOLDINGS LTD. |
13F
Company
|
2.5%
|
$519,661,463
28,838,039 shares
|
— | 30 Sep 2024 |
| Lingotto Investment Management LLP |
13F
Company
|
2.3%
|
$477,593,539
26,503,526 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
576
Shares
665,647,648
Rows available
576
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
537
Q4 2024 holders
576
Holder diff
39
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|